We are live on ! Find out more
CIP

Convergence Investment Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
+9.02%
1 Year Est. Return
+87.75%
3 Year Est. Return
+284.25%
5 Year Est. Return
+379.02%
10 Year Est. Return
+1,390.46%
AUM
$745M
AUM Growth
+$38.9M
Cap. Flow
-$8.7M
Cap. Flow %
-1.17%
Top 10 Hldgs %
13.84%
Holding
386
New
73
Increased
101
Reduced
114
Closed
94

Top Buys

Rank Stock Value
1
CAT icon
Caterpillar
CAT
+$6.78M
2
GIS icon
General Mills
GIS
+$4.44M
3
ORCL icon
Oracle
ORCL
+$4.14M
4
NFLX icon
Netflix
NFLX
+$3.91M
5
MYGN icon
Myriad Genetics
MYGN
+$3.72M

Sector Composition

Rank Sector Weight
1 Financials 17.28%
2 Technology 13.41%
3 Industrials 13.28%
4 Healthcare 12.55%
5 Consumer Discretionary 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMKR icon
126
Amkor Technology
AMKR
$13.9B
$2.02M 0.27%
+201,187
New +$2.15M
FAF icon
127
First American
FAF
$7.76B
$2.02M 0.27%
35,986
-8,317
-19% -$448K
LGND icon
128
Ligand Pharmaceuticals
LGND
$6.01B
$2.02M 0.27%
23,583
+1,939
+9% +$168K
VRTX icon
129
Vertex Pharmaceuticals
VRTX
$121B
$2.01M 0.27%
13,393
-563
-4% -$83.4K
LEA icon
130
Lear
LEA
$6.22B
$2M 0.27%
11,335
-1,038
-8% -$182K
RCL icon
131
Royal Caribbean
RCL
$87.5B
$1.99M 0.27%
16,709
+895
+6% +$111K
ADM icon
132
Archer Daniels Midland
ADM
$38.4B
$1.99M 0.27%
49,557
-83,330
-63% -$3.43M
PBF icon
133
PBF Energy
PBF
$7.82B
$1.98M 0.27%
55,791
+34,875
+167% +$1.08M
SUPN icon
134
Supernus Pharmaceuticals
SUPN
$2.53B
$1.97M 0.26%
49,345
+2,385
+5% +$94.2K
WLK icon
135
Westlake Corp
WLK
$10.3B
$1.96M 0.26%
+18,440
New +$1.71M
CADE
136
DELISTED
Cadence Bank
CADE
$1.96M 0.26%
+62,254
New +$2M
FHI icon
137
Federated Hermes
FHI
$4.81B
$1.96M 0.26%
54,172
-971
-2% -$31.4K
LYB icon
138
LyondellBasell Industries
LYB
$19.8B
$1.93M 0.26%
17,507
-274
-2% -$28.4K
NTGR icon
139
NETGEAR
NTGR
$654M
$1.9M 0.25%
+32,295
New +$1.65M
ETR icon
140
Entergy
ETR
$51B
$1.87M 0.25%
45,958
+2,402
+6% +$101K
INVA icon
141
Innoviva
INVA
$1.54B
$1.85M 0.25%
130,211
+7,350
+6% +$98K
PRLB icon
142
Protolabs
PRLB
$2.13B
$1.84M 0.25%
17,895
-95
-0.5% -$8.53K
SYKE
143
DELISTED
SYKES Enterprises Inc
SYKE
$1.84M 0.25%
58,585
CBRE icon
144
CBRE Group
CBRE
$43.8B
$1.84M 0.25%
+42,413
New +$1.76M
TGT icon
145
Target
TGT
$67.3B
$1.81M 0.24%
27,780
-55,585
-67% -$3.36M
PRU icon
146
Prudential Financial
PRU
$42.9B
$1.8M 0.24%
15,682
-184
-1% -$20.7K
PFG icon
147
Principal Financial Group
PFG
$24.7B
$1.8M 0.24%
25,459
-769
-3% -$53K
DPLO
148
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$1.78M 0.24%
+88,574
New +$1.74M
QCOM icon
149
Qualcomm
QCOM
$171B
$1.77M 0.24%
27,711
-614
-2% -$37.2K
RDN icon
150
Radian Group
RDN
$5.28B
$1.77M 0.24%
86,025
-21,953
-20% -$453K

Similar funds

Convergence Investment Partners's Q4 2017 Portfolio in Review

As of Q4 2017, Convergence Investment Partners held 386 positions worth $745M, up 5.5% from $706M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Convergence Investment Partners's Q4 2017 filing shows 73 new, 101 increased, 114 reduced and 94 closed positions. Its largest new stake was Caterpillar: 48,884 shares worth $7.7M. The largest sale was Celgene Corp, an estimated $5.18M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.

  • Convergence Investment Partners's largest Q4 2017 buy was Caterpillar: 48,884 shares worth $7.7M.
  • Convergence Investment Partners added most to Oracle in Q4 2017, an estimated $4.14M increase.
  • Convergence Investment Partners's biggest Q4 2017 reduction was Travelport Worldwide Limited, cutting an estimated $3.73M.
  • Convergence Investment Partners fully exited Celgene Corp in Q4 2017, selling an estimated $5.18M.
  • Convergence Investment Partners's ten largest holdings make up 14% of its $745M portfolio in Q4 2017.
  • Convergence Investment Partners opened 73 new positions and closed 94 in Q4 2017.
  • Convergence Investment Partners's portfolio value rose 5.5% quarter-over-quarter to $745M.

Based on Convergence Investment Partners's 13F filing for Q4 2017, filed 16 Jan 2018.